Reuters logo
BRIEF-Kiadis Pharma FY operating loss narrows to 11.4 million euros
March 31, 2017 / 5:12 AM / 8 months ago

BRIEF-Kiadis Pharma FY operating loss narrows to 11.4 million euros

March 31 (Reuters) - Kiadis Pharma NV:

* Kiadis pharma announces annual results for the year ended december 31, 2016

* Cash position decreased to 14.6 million euros at year-end 2016 compared to 28.7 million euros at end of 2015

* FY net loss 14.8 million euros ($15.80 million) versus loss of 16.5 million euros year ago

* FY operating loss of 11.4 million euros versus loss of 16.0 million euros year ago Source text for Eikon: Further company coverage: ($1 = 0.9368 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below